Therefore, the purpose of this study was to explore the antidepressant-like effect of VD3 at different doses by the implications of the BDNF and neurotrophin signaling pathways, as well as the HPA axis, on a rat model of depression produced by CUMS. This evidence concerns the gene BDNF and depressive symptom measurement.